Depressor effects with sympathomimetic amines after blockade of cardiovascular alpha-receptors.
D000818:Animals; D001794:Blood Pressure; D002319:Cardiovascular System / Q000187:drug effects*; D002396:Catechols / Q000494:pharmacology; D002415:Cats; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology*; D004878:Ergotamine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology*; D009647:Normetanephrine / Q000494:pharmacology*; D010627:Phenethylamines / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011984:Sensory Receptor Cells / Q000187:drug effects*; D013566:Sympathomimetics / Q000494:pharmacology*; D014439:Tyramine / Q000494:pharmacology
D002396:Catechols; D010627:Phenethylamines; D013566:Sympathomimetics; D009647:Normetanephrine; D010643:Phenoxybenzamine; D004295:Dihydroxyphenylalanine; D011433:Propranolol; D004878:Ergotamine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine